Innovation Hub / Podcasts
Podcast Q&A: EU HTA Joint Clinical Assessments
March 14, 2024
In this episode of tHEORetically Speaking, join Dr. Rosemary Jose, Dr. Sonja Kroep, and Nick Halfpenny from OPEN Health, Dr. Ansgar Hebborn from Roche, and James Ryan from AstraZeneca, who answer questions from a recent webinar on several policy aspects regarding the current challenges and implications of the EU Health Technology Assessment (HTA) regulation.
Weekly News Roundup - PhRMA Leadership Transition, The ICHRA Shift, and MDUFA VI Preliminary Deal
Talking Real Science with Stella Goulopoulou
Talking Real Science with Yelena Akelina
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments
Talking Real Science with Licy Yanes Cardozo
Industry Insights with Bas Trietsch and STEMCELL Technologies
Talking Real Science with Helen Collins
Talking Real Science with Rachel Buckley
Talking Real Science with Meaghan Loy on Rare Disease Day